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Abstract
Background: A number of studies have reported low uptake of cancer screening programmes by South Asian populations in
the UK. However, studies to date have not adjusted findings for differences in demographics and socio-economic status of these
populations.
Methods: Subjects: All residents in Coventry and Warwickshire, UK, eligible for screening. Uptakes compared for round 1
(2000–02) and round 2 (2003–05) of a national bowel cancer screening pilot, and for rounds 1, 2 and 5 of the established NHS
breast cancer screening programme (commenced 1989).
Data: Bowel screening data were analysed for 123,367 invitees in round 1 and 116,773 in round 2 (total 240,140 cases). Breast
screening data were analysed for 61,934, 62,829 and 86,749 invitees in rounds 1, 2 and 5 respectively (total 211,512 cases).
Analysis: Screening uptake was compared for two broad meta-categories (South Asian and non-Asian) and for five Asian
subgroups (Hindu-Gujarati; Hindu-Other; Muslim; Sikh; South Asian Other). Univariate and multivariate analyses examined
screening uptake and various demographic attributes of invitees, including age, gender, deprivation and ethnic group.
Results: South Asians demonstrated significantly lower (p < 0.001) unadjusted bowel screening uptake; 32.8% vs. 61.3% for
non-Asians (round 1). Rates were particularly low for the Muslim subgroup: 26.1% (round 1), 21.5% (round 2). For breast
screening, a smaller difference was observed between South Asians and non-Asians; initially 60.8% vs. 75.4% (round 1) and later
66.8% vs. 77.7% (round 5). Thus, the disparity reduced gradually over time, alongside an overall trend of increased uptake.
However, figures remained consistently low for Muslims (51% in rounds 1 and 5). After adjusting for age, deprivation (and
gender), bowel screening uptake remained significantly lower for all South Asian subgroups. After similar adjustments, breast
screening uptake remained lower for all subgroups except Hindu-Gujaratis.
For Muslims registered with an Asian (vs. non-Asian) GP, bowel screening uptake was significantly lower (p < 0.001). However,
breast screening uptake for Muslims with an Asian (vs. non-Asian) GP showed no difference (p = 0.12) in the same period.
Colonoscopy and breast assessment uptakes were similar for both meta-categories, but Asian response time appeared slower
for colonoscopy. The percentage of abnormal FOBT results was significantly higher for South Asian invitees. A slight increase
in abnormal mammograms was observed for Muslims over time (2.7% to 4.2% in rounds 1 and 5 respectively).
Conclusion: The lower cancer screening uptakes observed for the South Asian population cannot be attributed to socio-
economic, age or gender population differences. Although breast screening disparities have reduced over time, significant
differences remain. We conclude that both programmes need to implement and assess interventions to reduce such differences.
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Background
Breast cancer is the most common cancer in women in the
United Kingdom (UK); bowel cancer is the second most
common, and the third most common cancer in men after
prostate and lung cancer [1]. Five year survival figures for
bowel cancer are on average below 50% with poor sur-
vival largely attributable to late detection of the disease
[2]. In contrast, five year survival for women diagnosed
with breast cancer is 76% [3] and for cancers detected by
screening 93% [4]. A population screening programme
for breast cancer, first introduced nationally in 1988, is
now well established in the UK.
Mammography uptake is approximately 71% at first invi-
tation, with values ranging from 55% in London to 76%
in other regions [5]. In 2000, the Department of Health
set up pilot site areas to assess the feasibility of introduc-
ing a population screening programme for bowel cancer
using faecal occult blood test (FOBT) kits completed at
home and returned to a laboratory for processing [6]. An
overall uptake level of 60% was reported in the pilot [7].
A number of international studies have highlighted ine-
qualities in access to cancer screening for people from
black and minority ethnic communities. In the UK, low
uptake levels for breast screening have been observed,
especially among South Asians [8-10]. In the United
States (US), low breast screening rates have been reported
for African-American women [11]. Although differences
have narrowed over time [12-14], rates for Hispanic
women appear to have remained lower than those for
other groups [15]. For bowel cancer screening, the litera-
ture also provides evidence of lower uptake by ethnic
minority communities. In the US, differences have been
reported both for established ethnic minority groups such
as African Americans [16-19] and for more recent immi-
grant Asian populations including Koreans, Japanese,
Chinese and South-East Asians [20-22]. Low levels of
bowel cancer screening have also been reported for immi-
grant populations in Europe [23]. In the UK, the impact of
population diversity on uptake of cancer screening was
not assessed in randomised controlled trials of FOBT
screening [24] or flexible sigmoidoscopy screening [25].
Studies which compare breast and bowel cancer screening
behaviour in the same population are limited; US research
has reported that uptake is far lower for bowel screening
than for breast screening among African American and
Hispanic women [15]. Unfortunately, most studies fail to
correct observed uptake differences for deprivation, so the
possibility of socio-economic status acting as a confound-
ing factor cannot be ruled out [26]. One study which has
addressed this issue found that deprivation could not fully
explain observed differences in uptake for bowel cancer
screening, especially for older US ethnic minority popula-
tions [15].
The present study has analysed uptake patterns in a com-
mon UK population for two cancer screening pro-
grammes over time: breast screening (beginning with
round 1 in 1989) and bowel cancer screening which
started in 2000. Uptake patterns for South Asian minority
groups have been compared to those for the majority pop-
ulation, adjusted for differences in demographics and
socio-economic status. The research was funded by the
National Health Service (NHS) Cancer Screening Pro-
grammes and the project was awarded Coventry Research
Ethics Committee approval (ref: 05/Q2802/2) on 27th
January 2005.
Methods
Setting
The study was undertaken in the English bowel cancer
screening pilot site (Coventry and Warwickshire). This
area has a population of over 800,000, including 8.7%
ethnic minority residents who are mainly of South Asian
origin. For breast screening all women aged 50–70 years
registered with a general practitioner (GP) in the area are
invited for mammography. The letter of invitation,
patient information leaflet explaining the importance of
breast cancer screening, and any reminders are all printed
in English, although GP practices do display patient infor-
mation leaflets in various languages. For bowel cancer
screening all men and women aged 50–69 years registered
with a GP are invited. For this programme, the invitation
letter contains a sentence in eleven languages (including
the main South Asian ones) explaining how a translated
patient information leaflet can be obtained. Instruction
leaflets explaining how to use the FOBT kit are in English.
Data Preparation
Data were downloaded from the records of the two cancer
screening programmes (Warwickshire, Solihull & Coven-
try Breast Screening Service; and the English Bowel Cancer
Screening Pilot, Coventry & Warwickshire). Selected items
were collated for all individuals invited to either cancer
screening programme. Breast cancer screening data were
obtained for round 1 (1989 – 1992), round 2 (1992 –
1995) and round 5 (2001 – 2004). Bowel screening data
for round 1 (2000 – 2002) and round 2 (2003 – 2005).
Data items extracted included demographic descriptors
(age, sex, postcode of residence), screening invitation
date, GP details, screening outcome, and final diagnosis.
For bowel cancer, screening outcomes included: individ-
ual's response to home testing invitation; number of
FOBT kits completed; screening test result; response to
colonoscopy invitation if FOBT positive; and diagnostic
outcome. For breast cancer, screening outcomes included:
response to mammography invitation; mammography
result; response to assessment invitation if an irregularity
is found in the mammogram; and diagnostic outcome. To
ensure reliability, individuals were removed from the dataBMC Public Health 2008, 8:346 http://www.biomedcentral.com/1471-2458/8/346
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files if: excluded from screening by the Health Authority
e.g. address not found; individual undergoing treatment
or recently deceased; outside the specified age range; or
received a second invitation within the screening round
period (in which case only the earliest record was
retained).
Deprivation
The South Asian population in the study area is concen-
trated in distinct locations. The postcode of residence was
used to link UK Census data on deprivation from the Cen-
sus Dissemination Unit (MIMAS, University of Manches-
ter, England) to individuals. Linkage was undertaken at
electoral ward level for the 1991 Census and at Central
Area Statistic ward level for the 2001 Census; these areas
are designed to be homogeneous in socio-economic char-
acteristics. The Carstairs Index of Deprivation, with cut-off
values for England, was used as the indicator of depriva-
tion [7]. 1991 deprivation scores were used for rounds 1
and 2 of the breast screening programme; 2001 scores
were used for later breast screening (round 5) and both
bowel screening rounds.
Ethnicity
Ethnicity is poorly recorded in the UK, especially in pri-
mary care [27-29]. This frequently precludes even the
most basic analysis of inequalities in access to services
[30-33]. The present study used name recognition soft-
ware which offers a useful alternative for identification of
populations with distinctive names, such as South Asians
[34-36]. The software was validated on local name data-
sets containing (gold standard) self-assigned ethnicity;
this demonstrated sensitivity/specificity values of 95%
and 97% respectively [37,38]. Further refinement using
manual checking by experts of the 180,000 names
assigned by the software produced an estimated final sen-
sitivity of 97%. The software was used to assign invitees to
the following religio-linguistic groups: Hindu-Gujarati;
Hindu-Other; Muslim; Sikh; South Asian Other; non-
Asian. The meta-category 'South Asian' refers to the first
five groups combined. The ethnic origin of GPs was deter-
mined using the same software.
Analysis
For breast screening, uptake levels were compared at two
stages in the screening process: (i) attendance for mam-
mography in response to a routine screening invitation;
(ii) attendance for further assessment if an irregularity was
found in the mammogram. For bowel cancer screening,
uptake levels were compared at three stages: (i) return of
an initial FOBT kit, even if this proved to be inadequately
completed; (ii) successful completion of a home FOBT
kit; (iii) for those with a positive FOBT result, attendance
for a colonoscopy appointment. Cases were excluded if
medical unfitness or other legitimate explanations were
recorded as reasons for failure to perform the colonos-
copy.
Logistic regression was used to explore associations
between levels of screening uptake and various demo-
graphic attributes of invitees. Both unadjusted and
adjusted odds ratios (point estimates and 95% confidence
intervals) were calculated. The adjusted analyses were
used to control uptake in different ethnic groups for fac-
tors such as gender (bowel screening only), age and dep-
rivation. Age was categorised into four bands (50–54; 55–
59; 60–64; 65–69) and deprivation into five bands.
The study also explored the possible influence of GP char-
acteristics, with a particular focus on ethnicity. For breast
screening this analysis was undertaken only on round 5
data, since historical information on GPs was unavailable
for rounds 1 and 2.
Results
Figures 1 and 2 present flowcharts showing the final pop-
ulations included in analysis of breast and bowel cancer
screening datasets respectively. In 0.5% of bowel and
0.7% of breast invitees a deprivation index could not be
computed due to missing postcode data. The religio-lin-
guistic indicator could be attached to all except 2 cases.
Relationship between screening uptake and invitee 
characteristics
Breast screening uptake for the South Asian population
was significantly lower than for non-Asians in all 3
rounds. In round 1, the observed uptake was 60.8% for
South Asians compared to 75.4% for non-Asians; giving a
difference of 14.6% (95% confidence interval (CI): 12.6
to 16.5). In round 2, the difference was 12.6% (95% CI:
10.8 to 14.4) and in round 5 it was 10.9% (95% CI: 9.4 to
12.3). Thus, there is evidence that the disparity in breast
screening uptake is reducing gradually over time. For
bowel screening, the observed differences are larger than
for breast screening. In round 1, the South Asians' com-
pletion rate of 32.8% was approximately half of that for
non-Asians (61.3%), giving a difference of 28.5% (95%
CI: 27.3 to 29.6). Figures for round 2 were 29.6% for
South Asians compared to 55.8% for non-Asians, giving a
difference of 26.2% (95% CI: 25.2 to 27.3).
When uptake levels are examined at the subgroup level,
further differences emerge. For breast screening, Hindu-
Gujarati women exhibited the highest initial uptake
(round 1). This has increased over time so that by round
5 their uptake was not significantly different from that of
non-Asian women (p = 0.19). Breast screening uptake has
failed to improve for only one subgroup (Muslim
women). For bowel cancer screening, in contrast, uptake
levels have decreased slightly between rounds for allBMC Public Health 2008, 8:346 http://www.biomedcentral.com/1471-2458/8/346
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groups. However, once again, Muslim invitees have the
lowest levels of FOBT completion and the Hindu-Gujarati
population the highest. Hindu-Gujaratis are the only sub-
group to show a (slight) narrowing of the gap with non-
Asian invitees. When compared to the uptake for all other
South Asian subgroups combined, Muslims exhibit a sig-
nificantly lower bowel screening uptake in both rounds (p
< 0.001).
Flowchart detailing process for obtaining breast screening populations for analysis Figure 1
Flowchart detailing process for obtaining breast screening populations for analysis.
Repeated
Records?
Yes Round 1:
1840
Round 2:
2207
Round 5:
7686
Reason for exclusion
Episode Type: recurrent
case, interval case, GP
referral, self referral, early
recall or other
Excluded by Health
Authority
Floating cases
(unattached GP details)
No
Round 1:
3645
Round 2:
2612
Round 5:
5201
Yes
Age <50 or
70+?
Round 1:
274
Round 2:
185
Round 5:
3748
Restricted
Population
No
No
Yes
Breast Screening
Population Download
Round 1:
65853 invitees
(67693 records)
Round 2:
65628 invitees
(67833 records)
Round 5:
95698 invitees
(103384 records)
Round 1:
61934 invitees
Round 2:
 62829 invitees
Round 5:
 86749 invitees
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Flowchart detailing process for obtaining bowel screening populations for analysis Figure 2
Flowchart detailing process for obtaining bowel screening populations for analysis.
Bowel Screening
Population Download
Round 1:
189319 invitees
Round 2:
137393 invitees
Missing NHS
Number?
Round 1:
399
Round 2:
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Yes
No
Reason for Closing Episode:
MISSING reason
Ceased
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Deceased
Deducted by Health Authority
Duplicate registration/existing episode*
Other
Polyp surveillance*
Recently screened
Undelivered, pending deduction
Round 1:
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Round 2:
15687
Yes
No
Age < 50 or 70+?
Yes
Restricted
Population
Round 1:
 123367 invitees
Round 2:
  116773 invitees
Round 1:
8 (< 50)
28 (70+)
Round 2:
497 (< 50)
353 (70+)
* Round 2 only
No
Excluded GP
practice patient?
No
Yes Round 1:
58009
Round 2:
3167
(boundary
practices)
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Figure 3 shows that breast screening uptake demonstrates
a decrease with age in all three rounds for both South
Asians and non-Asians (p  < 0.001). For bowel cancer
screening, there is an increased uptake with age for the
non-Asian population in both rounds (p < 0.001). For
South Asians, however, the effect of age is less marked and
above the 55–59 year age group there is no significant
increase (p = 0.53 and p = 0.71 for rounds 1 and 2 respec-
tively).
In the bowel screening programme, the gender balance of
invitees from the South Asian and non-Asian communi-
ties was identical, at 50% (± 0.2%) males. FOBT uptake
was generally lower for males than for females in both
groups, although this difference in the South Asian popu-
lation is much smaller. In round 1, uptake by non-Asian
males (56.6%) was significantly lower than for females
(66.0%); a difference of 9.4% (95% CI: 8.8 to 9.9). Simi-
larly in round 2, the male figure was 51.5% and the differ-
ence observed was 8.6% (95% CI: 7.0 to 9.2). In contrast,
for the South Asian population, gender differences are less
significant; in round 1, a difference of 1.1% (95% CI: -1.2
to 3.3), and in round 2 a difference of 1.5% (95% CI: -0.5
to 3.6).
The influence of socio-economic status on uptake of
breast screening is shown in Figure 4. For non-Asian
invitees, uptake clearly decreases with increased depriva-
tion in all 3 rounds (p < 0.001). This pattern appears less
pronounced for South Asian invitees, with a decrease only
evident in later rounds (p ≤ 0.001 rounds 2 and 5). In the
most deprived group, there is no evidence of a difference
in uptake between South Asian and non-Asian invitees in
round 1 (p = 0.60) or round 2 (p = 0.24), although a sig-
nificant difference is apparent in round 5 (p < 0.001). For
bowel cancer screening, Figure 5 shows that uptake once
again decreases with increased deprivation for non-Asian
invitees in both rounds (p < 0.001). For the South Asian
invitees, on the other hand, uptake remains relatively con-
stant apart from a decrease for the most deprived group in
both rounds. Overall, the strength of any link between
deprivation and screening uptake is less evident in the
South Asian population for both screening programmes.
Multivariate analysis
Tables 1, 2, 3 show the results from the main effects logis-
tic regression model, including adjusted odds ratios with
corresponding 95% confidence intervals. For breast
screening, three invitee characteristics were included (age,
deprivation and ethnicity); for bowel screening gender
was also included in the regression model. Multivariate
analyses excluded the 'South Asian Other' group due to
low numbers.
For breast screening, the adjusted odds ratio for the total
population decreases with increasing age in all three
rounds (Table 1), indicating that older women are less
likely to undertake screening, even if their other character-
istics such as deprivation and ethnicity are taken into
account. Similarly, deprivation has a very strong influence
on breast screening behaviour in all 3 rounds (Table 2),
with women in the highest deprivation category two or
three times less likely to undertake screening than women
in the least deprived category, particularly in rounds 1 and
2. For bowel cancer screening, Table 1 shows that, in con-
trast to breast screening, uptake levels increase with age.
The adjusted odds of undertaking screening are over 1.5
times higher in the oldest age group compared to the
youngest reference age group. Adjusted odds are also
higher for the female population in both rounds (Table
1), although differences appear to be slightly lower in
round 2 than in round 1. As is observed for breast screen-
ing, uptake decreases with increased deprivation in both
rounds (Table 2), with the odds of undertaking screening,
after adjusting for age, gender and ethnicity, less than half
for invitees in the most deprived group.
The major uptake differences are linked to ethnicity
(Table 3). For bowel screening, even after adjusting for
age, gender and socio-economic status, there are clear dif-
ferences between those in South Asian subgroups com-
pared to the non-Asian reference group. In particular, the
adjusted odds ratios show that the likelihood that a Mus-
lim invitee will successfully complete the FOBT home
screening test is approximately one third that of a non-
Asian invitee. Even for the ethnic subgroup with the high-
est uptake (Hindu-Gujarati), the adjusted odds are 0.5. It
appears that lower bowel cancer screening uptake levels in
the South Asian population cannot be explained by differ-
ences in other characteristics such as deprivation. The
remaining two groups (Sikh and Hindu-Other) demon-
strate lower uptake of bowel screening compared to the
non-Asian reference group, although differences are not as
marked as those seen in the Muslim population. Simi-
larly, for breast screening the adjusted odds ratios indicate
significant differences, with lower screening uptake
among South Asian invitees. Muslim women show a
decrease in the adjusted odds ratio over rounds 1 to 5,
while adjusted odds ratios for the Hindu-Gujarati popula-
tion are not significantly different to those for the non-
Asian population. Once again, Sikh and Hindu-Other
groups demonstrate lower uptakes compared to the non-
Asian and Hindu-Gujarati groups, although not as low as
those observed for Muslim women.
Screening uptake and GP characteristics
Nearly two thirds of South Asian women invited to under-
take breast screening are registered with a South Asian GP;
a similar pattern is observable at the ethnic subgroupBMC Public Health 2008, 8:346 http://www.biomedcentral.com/1471-2458/8/346
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Breast & bowel screening uptake by age group Figure 3
Breast and bowel screening uptake by age group.
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Breast screening uptake by deprivation group Figure 4
Breast screening uptake by deprivation group.
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level. Differences in breast screening uptake for those reg-
istered with a South Asian vs. non-Asian GP are largest for
Muslim women (49.4% vs. 54.9% respectively), although
this difference is not significant (p = 0.12). For bowel can-
cer screening, however, much larger differences in uptake
are observed, especially for the Muslim population. Anal-
ysis confirms that there are significant (p < 0.001) differ-
ences for Muslims in round 1 (22.9% for women
registered with a South Asian GP vs. 38.0% for those reg-
istered with a non-Asian GP), giving a difference of 15.1%
(95% CI: 9.6 to 20.8); and for round 2 (p < 0.001) with
figures of 19.2% and 27.4% respectively, giving a differ-
ence of 8.2% (95% CI: 3.8 to 12.8).
Screening and diagnostic outcomes
Although irregularities were found to be more likely in
non-Asian mammograms than for South Asian women in
all 3 rounds, these differences were not significant (p >
0.1). In contrast, for bowel screening in both rounds the
percentage of abnormal FOBT results was significantly
higher for South Asian invitees; 3.1% (95% CI: 2.4 to 3.9)
in round 1, and 4.7% (95% CI: 3.9 to 5.7) in round 2 vs.
1.2% and 1.4% respectively for non-Asians. Following an
irregularity in the mammogram, all women attended for
further assessment regardless of their ethnicity. Similarly,
colonoscopy uptake rates were identical at 6 months,
regardless of ethnicity. However, there is evidence of some
delay for the South Asian patients, which has increased
over rounds. In round 1, 85% of South Asian patients as
opposed to 90% of non-Asian patients undertook colon-
oscopy within 3 months of obtaining the abnormal FOBT
result. In round 2, comparable figures were 79% for South
Asians and 89% for non-Asians. (p = 0.05).
Following breast assessment, a higher percentage of
abnormal results are recorded among South Asians,
although this difference is not statistically significant (p >
0.1 in all rounds). Following colonoscopy, the likelihood
of detecting bowel cancer is not significantly different
between South Asians and non-Asians. It should be noted,
however, that numbers in both cases are very low.
Bowel screening uptake by deprivation group Figure 5
Bowel screening uptake by deprivation group.
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Discussion
In the UK, various policy documents [39,40] and the legal
requirements set out in the Race Relations (Amendment)
Act 2000 [41] have all called for a change from the con-
cept of 'average citizen' to one that recognises diversity. A
recent review of 'ethnic issues in screening' produced by
the NHS National Screening Committee [42] has recom-
mended that all nationally managed screening pro-
grammes ensure effective demographic data collection
(including data on ethnicity) and assess the likely impact
of any new policy on the promotion of race equality.
The findings presented in this paper are important
because they represent the first body of systematic
research evidence based on individual patients in different
South Asian populations. This provides robust evidence of
disparities in screening uptake for existing and new cancer
screening programmes even after adjusting for differences
in demographics and socio-economic status. With nearly
one in ten UK citizens from a minority ethnic back-
ground, improved understanding of how the offer of can-
cer screening is received by different populations is an
increasingly important issue [43,44]. Our findings sup-
port evidence from earlier analyses based on practice-level
data, indicating that cancer screening uptake might be sig-
nificantly lower in certain ethnic minority populations
such as South Asians [8].
Our analysis over screening rounds shows that breast
screening uptake has improved for the South Asian popu-
lation at a faster rate than for the majority population,
with the net result that differences between the two popu-
lations have reduced significantly from 14.6% in 1989–92
to 10.9% in 2003–05, although a significant disparity
remains. Our findings are similar to those from the US
where differences in mammography uptake are reported
t o  ha v e  n a r ro w e d  ov e r  t i me  [ 1 2- 1 4 ] ;  th i s  d e cr e a s e  ha s
occurred against the background of a general increase in
breast screening uptake rates for eligible women [45], sim-
ilar to the pattern we identify, and of lower breast screen-
ing uptakes by women of African-American, Hispanic and
Native-American origin [11,46-51]. The difference we
report is however smaller than the 78% vs. 53% disparity
reported by another 2001 UK study [52], although this
study was undertaken in an area with 61% Muslims in the
South Asian population [53]. At the subgroup level, our
findings demonstrate that the Hindu-Gujarati population
achieved parity with the majority population over the
period up to 2005, while Muslim women are the only
group for whom breast screening uptake has not
Table 1: Multivariate analysis: breast and bowel screening uptakes by age group and gender
Cancer screening Programme/Round Age Number Uptake (%) Adjusted OR (95% CI)
50–54 17453 77.13 1 (-)
55–59 20307 76.63 0.97+ (0.92, 1.02)
Breast screening 60–64 20081 72.16 0.78** (0.74, 0.82)
Round 1: 1989–92 65–69 4051 68.28 0.65** (0.60, 0.71)
50–54 19176 78.99 1 (-)
55–59 20894 78.15 0.96+ (0.91, 1.01)
Breast screening 60–64 19144 74.68 0.79** (0.75, 0.83)
Round 2: 1992–95 65–69 3577 69.33 0.61** (0.56, 0.67)
50–54 26909 78.71 1 (-)
55–59 26175 78.93 1.00+ (0.96, 1.04)
Breast screening 60–64 19733 76.93 0.91** (0.87, 0.95)
Round 5: 2001–04 65–69 13394 73.32 0.75** (0.71, 0.79)
50 – 54 36832 54.74 1 (-)
55 – 59 34931 29.30 1.18** (1.15, 1.22)
Bowel screening 60 – 64 27518 62.58 1.41** (1.36, 1.45)
Round 1: 2000–02 65 – 69 23968 64.86 1.56** (1.51, 1.61)
50 – 54 32426 47.44 1 (-)
55 – 59 34309 52.88 1.21** (1.17, 1.24)
Bowel screening 60 – 64 27336 57.69 1.49** (1.44, 1.54)
Round 2: 2003–05 65 – 69 22588 61.44 1.77** (1.71, 1.84)
Cancer screening Programme/Round Gender Number Uptake (%) Adjusted OR (95% CI)
Bowel screening Male 61650 55.30 1 (-)
Round 1: 2000–02 Female 61599 64.21 1.46** (1.43, 1.50)
Bowel screening Male 58395 50.08 1 (-)
Round 2: 2003–05 Female 58264 58.21 1.39** (1.36, 1.43)
+Non-significant p > 0.05
** Significant at p < 0.001BMC Public Health 2008, 8:346 http://www.biomedcentral.com/1471-2458/8/346
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improved over time. A slight increase in abnormal mam-
mograms was observed for Muslims over time (2.7% to
4.2% in rounds 1 and 5 respectively). It is interesting to
note that uptake rates for Hispanic women also appear to
have remained lower than for other groups such as Afri-
can-American or Caucasian women in the US [15].
Although our findings indicate that breast screening
uptake has improved for all age groups over time in both
populations, South Asian women, especially older
women, continue to exhibit a significantly lower uptake.
In the US, mammography uptake is similarly reported to
fall with age; the regularity with which women undertake
screening also varies, with older women, African-Ameri-
cans and those from more deprived populations showing
more infrequent use [11,12]. In our study a slight increase
in abnormal mammograms was observed for Muslims
over time which might be linked to less frequent screening
use.
Our findings indicate a general pattern of lower breast
screening uptake in more deprived groups for both South
Asian and non-South Asian populations, although the
effect is far less pronounced for South Asians. Most impor-
tantly, our multivariate analysis shows that lower breast
screening uptake rates in the South Asian population can-
not be explained by factors such as deprivation. At a GP
practice level, other researchers have identified social dep-
rivation and ethnic-mix in the local population as corre-
lated with breast screening rates in the UK [54]. However,
the possible confounding effect of deprivation has gener-
ally not been separated from that of ethnicity. In the US,
various socio-economic characteristics e.g. income, educa-
tion, insurance status appear to characterise populations
with lower rates of breast cancer screening, with some
research evidence emerging to indicate that ethnic dispar-
ities in uptake remain even after allowing for socio-eco-
nomic differences [11,55-57].
For bowel cancer screening, our results show that the glo-
bal uptake level achieved (60%) masks significantly lower
uptake rates for South Asians; differences are even greater
than those observed for breast screening. Both men and
women from the South Asian community are far less
likely to return an initial home test kit or to subsequently
successfully complete the testing process, than are non-
Asians. Evidence from other countries demonstrates a
similarly low uptake of bowel cancer screening (FOBT,
colonoscopy and flexible sigmoidoscopy) by ethnic
Table 2: Multivariate analysis: breast and bowel screening uptakes by deprivation
Cancer screening Programme/Round Deprivation Number Uptake (%) Adjusted OR (95% CI)
1 & 2 (Least) 15535 80.86 1 (-)
3 17387 78.35 0.87** (0.82, 0.91)
Breast screening 4 15894 72.54 0.64** (0.61, 0.68)
Round 1: 1989–92 5 5224 68.09 0.53** (0.49, 0.56)
6 & 7 (Most) 3193 61.13 0.41** (0.38, 0.45)
1 & 2 (Least) 17374 80.99 1 (-)
3 18390 79.28 0.91** (0.86, 0.95)
Breast screening 4 15847 75.12 0.73** (0.69, 0.77)
Round 2: 1992–95 5 5051 68.62 0.53** (0.50, 0.57)
6 & 7 (Most) 3020 61.39 0.42** (0.38, 0.45)
1 (Least) 16903 82.18 1 (-)
2 17002 81.27 0.95+ (0.90, 1.00)
Breast screening 3 17228 80.50 0.91** (0.86, 0.96)
Round 5: 2001–04 4 17117 76.37 0.72** (0.68, 0.76)
5 (Most) 17351 67.60 0.48** (0.45, 0.50)
1 (Least) 16107 67.78 1 (-)
2 23420 66.95 0.96* (0.92, 1.00)
Bowel screening 3 25225 65.03 0.88** (0.84, 0.91)
Round 1: 2000–02 4 28301 58.68 0.68** (0.66, 0.71)
5 (Most) 29855 46.34 0.44** (0.42, 0.45)
1 (Least) 14444 63.18 1 (-)
2 21831 61.45 0.92** (0.88, 0.96)
Bowel screening 3 24090 59.55 0.84** (0.81, 0.88)
Round 2: 2003–05 4 26852 52.80 0.66** (0.63, 0.68)
5 (Most) 28823 40.98 0.43** (0.41, 0.45)
+ Non-significant p > 0.05
* Significant at p < 0.05
** Significant at p < 0.001BMC Public Health 2008, 8:346 http://www.biomedcentral.com/1471-2458/8/346
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minority populations [15-19,23,58-60]. Studies of Amer-
ican Asian immigrant populations e.g. Koreans and Viet-
namese report similar findings [20-22,61]. Once again,
very few of these studies have controlled uptake for differ-
ences in socio-economic status, but those that have report
inconsistent findings [15,58,59]. The present study pro-
vides clear evidence that 'ethnicity', although it may corre-
late with socio-economic status, exerts a separate effect on
response to bowel cancer screening. There is also evidence
of some delay in the South Asian population before
undertaking colonoscopy.
The findings reported in this paper add to the developing
evidence base on disparities in access to a range of services
by ethnic minorities [62,63]. It might be anticipated that
bowel cancer screening would present greater barriers for
ethnic minorities than breast screening. Home FOBT test-
ing requires that individuals not only understand the ben-
efits of screening, but also that they are able to follow
specific written instructions in order to collect and pre-
serve samples over a number of days. A separate analysis
of round 1 bowel screening data indicates that South
Asians who attempt an initial home testing are more likely
to be sent 4 or more kits before successful completion
(e.g. 28% of Muslims compared with only 3% of non-
Asians) [54]. South Asian women are found to exhibit
particularly low FOBT completion rates compared to their
non-Asian peers, especially among older women. This
may be linked to the provision of written materials,
including kit instructions, since Muslim and older South
Asian women are known to have particularly low literacy
levels [64,65].
The ethnicity of the GP also appeared to be associated
with lower uptake of bowel cancer screening by South
Asians in our study. The same effect was not observed for
breast screening. It is difficult to see why this should be
the case since GPs are not directly involved in the bowel
screening process. However, studies in other health care
systems have identified physician recommendation as a
significant predictor of FOBT uptake by ethnic minorities
[8,61,66,67].
The implications of our findings for roll-out of the UK
bowel cancer screening programme will be especially sig-
nificant for inner city areas where South Asian popula-
Table 3: Multivariate analysis: breast and bowel screening uptakes by ethnic subgroup
Cancer screening Programme/Round Ethnic Group Number Uptake (%) Adjusted OR (95% CI)
Hindu-Gujarati 477 67.71 0.93+ (0.75, 1.15)
Hindu Other 241 59.75 0.60** (0.45, 0.79)
Breast screening Muslim 567 51.32 0.49** (0.41, 0.58)
Round 1: 1989–92 Sikh 1245 63.37 0.67** (0.59, 0.76)
Non-Asian 59362 75.35 1 (-)
Hindu-Gujarati 522 69.73 0.86+ (0.71, 1.05)
Hindu Other 247 67.21 0.67** (0.51, 0.89)
Breast screening Muslim 582 53.26 0.46** (0.39, 0.54)
Round 2: 1992–95 Sikh 1313 67.56 0.69** (0.61, 0.78)
Non-Asian 60127 77.38 1 (-)
Hindu-Gujarati 758 75.86 1.13+ (0.95, 1.34)
Hindu Other 428 68.93 0.68** (0.56, 0.84)
Breast screening Muslim 912 51.75 0.40** (0.35, 0.46)
Round 5: 2001–04 Sikh 2067 70.59 0.79** (0.72, 0.88)
Non-Asian 82046 78.05 1 (-)
Hindu-Gujarati 1389 40.03 0.50** (0.45, 0.56)
Hindu-Other 681 34.51 0.38** (0.32, 0.44)
Bowel screening Muslim 1595 26.14 0.30** (0.27, 0.34)
Round 1: 2000–02 Sikh 3012 32.47 0.36** (0.33, 0.39)
Non-Asian 116572 61.30 1 (-)
Hindu-Gujarati 1478 37.01 0.55** (0.50, 0.62)
Hindu-Other 757 33.16 0.44** (0.38, 0.52)
Bowel screening Muslim 1807 21.47 0.29** (0.26, 0.33)
Round 2: 2003–05 Sikh 3378 29.66 0.39** (0.36, 0.42)
Non-Asian 109239 55.83 1 (-)
 Controlled for age, deprivation, gender (breast screening)
+Non-significant p > 0.05
*Significant at p < 0.05
**Significant at p < 0.001BMC Public Health 2008, 8:346 http://www.biomedcentral.com/1471-2458/8/346
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tions can reach 40% [53]. In order to ensure equity as well
as efficiency in the new bowel cancer screening pro-
gramme, this population will require special attention.
Interventions targeted at particular groups may be needed
in order to achieve more equitable uptake rates e.g. Mus-
lims or older South Asian women. At present there is lim-
ited research evidence to indicate what types of
intervention would prove most effective [68-71]. Equally
importantly, the continued disparity in breast screening
uptakes after two decades needs to be addressed. A recent
review of the literature on interventions to improve breast
screening uptake in diverse populations suggests that
combined approaches using access-enhancing and indi-
vidual-directed strategies are most effective [72].
Finally, it might be argued that the incidence of cancer
among South Asian populations in the UK is low, and that
the observed differences in screening uptake are therefore
relatively unimportant. However, the low cancer inci-
dences reported historically are increasingly seen as an
artefact of the stage of migration with reports of increased
incidence beginning to emerge [73-75]. One limitation of
the present study is that we are unable to draw any conclu-
sions about the African Caribbean population because of
incomplete ethnic monitoring data and the fact that name
recognition software cannot identify these individuals.
However, there was a relatively small population in the
study area (< 1%). The need to urgently improve routine
ethnic data collection to provide improved statistics on
cancer incidence and survival for all ethnic minority
groups in the UK has recently been highlighted [76].
Conclusion
We conclude that the low breast and bowel cancer screen-
ing uptake rates observed in the South Asian population
cannot be attributed to socio-economic or age/gender
population differences. Although disparities in breast
screening have reduced over time, they are still significant.
We would suggest that both programmes need to identify
and assess culturally appropriate interventions to reduce
these observed differences, including provision of tailored
health promotion materials for certain South Asian sub-
groups. It would appear that Muslim invitees registered
with a South Asian GP are a prime target for improved
bowel screening uptake. More detailed examination of
behaviour across the two screening programmes may also
help to identify women who have responded positively to
breast screening and could therefore be encouraged to
complete bowel screening successfully.
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